THTX Theratechnologies, Inc: Bathi resik saben saham sajrone 12 wulan pungkasan

The price chart on the GURU.Markets platform demonstrates EPS dynamics, which stand at 42.40. Theratechnologies Inc. (THTX) is valued by the market as a reliable expert in the therapy of HIV complications. Efficiency growth is driven by the implementation of AI and robotics for accelerated peptide synthesis. Meanwhile, the business relies on steady demand for medications for chronic patients, which guarantees a predictable cash flow regardless of economic cycles.
Rincian metrik keuangan lan pasar Theratechnologies Inc (THTX)

Annual earnings per share (EPS) growth measures the rate of change in net income attributable to a single common share relative to the same period last year. By analyzing the 12-month YoY change in net income per share, an investor assesses capital management efficiency and business scalability. This metric reflects real profitability dynamics, stripped of one-time factors. For Theratechnologies Inc. (THTX), the stability of this index is supported by steady demand for HIV therapy drugs and patent protection of margins.